AMP Capital Investors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-74,461
| Closed | -$8.94M | – | 271 |
|
|
2021
Q3 | $8.94M | Buy |
74,461
+18,855
| +34% | +$2.19M | 0.05% | 399 |
|
|
2021
Q2 | $6.67M | Sell |
55,606
-33,459
| -38% | -$3.67M | 0.03% | 527 |
|
|
2021
Q1 | $8.9M | Sell |
89,065
-313
| -0.4% | -$31.5K | 0.04% | 433 |
|
|
2020
Q4 | $8.97M | Buy |
89,378
+11,166
| +14% | +$1.18M | 0.05% | 418 |
|
|
2020
Q3 | $8.62M | Sell |
78,212
-13,148
| -14% | -$1.46M | 0.05% | 389 |
|
|
2020
Q2 | $9.67M | Sell |
91,360
-27,355
| -23% | -$2.83M | 0.06% | 328 |
|
|
2020
Q1 | $10.6M | Buy |
118,715
+25,947
| +28% | +$2.44M | 0.08% | 269 |
|
|
2019
Q4 | $9.28M | Sell |
92,768
-3,811
| -4% | -$359K | 0.05% | 394 |
|
|
2019
Q3 | $8.74M | Buy |
96,579
+9,542
| +11% | +$827K | 0.05% | 392 |
|
|
2019
Q2 | $7.13M | Sell |
87,037
-18,277
| -17% | -$1.43M | 0.04% | 446 |
|
|
2019
Q1 | $9.05M | Buy |
105,314
+35,862
| +52% | +$2.83M | 0.05% | 382 |
|
|
2018
Q4 | $5.25M | Buy |
69,452
+30,341
| +78% | +$2.37M | 0.03% | 488 |
|
|
2018
Q3 | $3.11M | Buy |
39,111
+29,786
| +319% | +$2.25M | 0.02% | 662 |
|
|
2018
Q2 | $655K | Hold |
9,325
| – | – | ﹤0.01% | 950 |
|
|
2018
Q1 | $655K | Sell |
9,325
-682
| -7% | -$47.2K | ﹤0.01% | 944 |
|
|
2017
Q4 | $694K | Sell |
10,007
-732
| -7% | -$49.4K | ﹤0.01% | 972 |
|
|
2017
Q3 | $728K | Hold |
10,739
| – | – | ﹤0.01% | 944 |
|
|
2017
Q2 | $733K | Sell |
10,739
-1,535
| -13% | -$100K | ﹤0.01% | 913 |
|
|
2017
Q1 | $765K | Hold |
12,274
| – | – | ﹤0.01% | 907 |
|
|
2016
Q4 | $672K | Sell |
12,274
-5,193
| -30% | -$295K | ﹤0.01% | 942 |
|
|
2016
Q3 | $1.15M | Sell |
17,467
-71,496
| -80% | -$4.67M | 0.01% | 840 |
|
|
2016
Q2 | $5.31M | Buy |
88,963
+52,258
| +142% | +$3.04M | 0.04% | 460 |
|
|
2016
Q1 | $2.08M | Buy |
36,705
+24,705
| +206% | +$1.48M | 0.01% | 695 |
|
|
2015
Q4 | $828K | Hold |
12,000
| – | – | 0.01% | 881 |
|
|
2015
Q3 | $751K | Buy |
+12,000
| New | +$789K | 0.01% | 886 |
|
|
2015
Q1 | – | Sell |
-73,354
| Closed | -$5.19M | – | 1165 |
|
|
2014
Q4 | $5.19M | Hold |
73,354
| – | – | 0.03% | 492 |
|
|
2014
Q3 | $5.28M | Sell |
73,354
-10,535
| -13% | -$771K | 0.03% | 484 |
|
|
2014
Q2 | $6.22M | Sell |
83,889
-39,531
| -32% | -$2.86M | 0.04% | 461 |
|
|
2014
Q1 | $8.05M | Sell |
123,420
-56,064
| -31% | -$3.62M | 0.05% | 393 |
|
|
2013
Q4 | $10.7M | Sell |
179,484
-98,797
| -36% | -$5.37M | 0.08% | 323 |
|
|
2013
Q3 | $14.4M | Sell |
278,281
-104,460
| -27% | -$5.25M | 0.11% | 214 |
|
|
2013
Q2 | $18.4M | Buy |
+382,741
| New | +$19.5M | 0.14% | 166 |
|
Other funds holding AZN
AMP Capital Investors's AZN Position: Q4 2021 in Review
AMP Capital Investors sold out of AstraZeneca (AZN) in Q4 2021, closing a stake of 74,461 shares — an estimated $8.94M sold.
AMP Capital Investors first reported a position in AZN in Q2 2013 and held it in 32 quarters. The position peaked at $18.4M in Q2 2013. 950 funds tracked by Wall St. Rank hold AZN as of Q4 2021.
- AMP Capital Investors reported no remaining AstraZeneca position as of Q4 2021 after selling out during the quarter.
- AMP Capital Investors sold 74,461 AstraZeneca shares in Q4 2021, an estimated $8.94M.
- AMP Capital Investors first reported a position in AstraZeneca in Q2 2013 and held it in 32 quarters.
- AMP Capital Investors's AstraZeneca position peaked at $18.4M in Q2 2013.
- 950 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2021.
Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.